Background: General practitioners (GPs) and other health professionals have a key role in signposting their patients to appropriate opportunities for engaging in arts and creative activities for the health and wellbeing benefits they may bring. Training is needed to ensure that GPs are aware of the evidence supporting the role of the arts, and the local availability of 'creative arts for health' activities for their patients.
Aim: This article describes the content and evaluation of three arts and health training events for trainee GPs conducted over the period 2016-2019. They took place in association with Guy's and St Thomas, Hillingdon and York and Scarborough General Practice Vocational Training Schemes (GPVTS).
Methods: Evaluation was undertaken for the London events using a specially constructed questionnaire, with rating scales, completed before and after the training events. For the York event, a simple bespoke evaluation questionnaire was employed at the end of the training day. All participants gave consent for photography and filming during the events.
Results: Feedback from GPs on the training events revealed increased awareness of the evidence for arts and health interventions, and more positive attitudes towards the role of creative arts in primary care in promoting the health and wellbeing of patients. An additional finding was a recognition by GP trainees that creative activities can enhance a holistic approach to patient care and play a positive part in supporting their own wellbeing.
Conclusion: Training events of the kind described, with opportunities for creative participation for GP trainees, can enhance awareness of the benefits of creative activity for patient health and wellbeing, and may motivate future GPs to signpost patients towards opportunities for engaging in creative activities. This training model is applicable for any health worker who can refer patients to arts for health activities and has potential to be scaled up nationally.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1177/1757913920924440 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Encorafenib, cetuximab and chemotherapy in BRAF-mutant colorectal cancer: a randomized phase 3 trial.
Nat Med
January 2025
Vall d'Hebron Hospital Campus and Vall d'Hebron Institute of Oncology (VHIO), University of Vic - Central University of Catalonia, Barcelona, Spain.
Encorafenib + cetuximab (EC) is approved for previously treated BRAF V600E-mutant metastatic colorectal cancer (mCRC) based on the BEACON phase 3 study. Historically, first-line treatment of BRAF V600E-mutant mCRC with chemotherapy regimens has had limited efficacy. The phase 3 BREAKWATER study investigated EC+mFOLFOX6 versus standard of care (SOC) in patients with previously untreated BRAF V600E mCRC.
View Article and Find Full Text PDFAdolescent mice exposed to TBI developed PD-like pathology in middle age.
Transl Psychiatry
January 2025
Department of Neurosurgery, General Hospital of Northern Theater Command, Postgraduate Training Base of General Hospital of Northern Theater Command of Jinzhou Medical University, Shenyang, Liaoning, China.
Traumatic brain injury (TBI) is identified as a risk factor for Parkinson's disease (PD), which is a neurodegenerative disease characterized by the loss of dopaminergic neurons in the substantia nigra (SN). However, the precise mechanism by which chronic TBI initiates PD pathogenesis is not yet fully understood. In our present study, we assessed the chronic progression and pathogenesis of PD-like behavior at different intervals in TBI mice.
View Article and Find Full Text PDFChromosome-level de novo genome unveils the evolution of Gleditsia sinensis and thorns development.
Genomics
January 2025
State Key Laboratory of Tree Genetics and Breeding, Laboratory of Forest Silviculture and Tree Cultivation, Research Institute of Forestry, Chinese Academy of Forestry, China. Electronic address:
Gleditsia sinensis Lam. (G. sinensis) as an important species within the Leguminosae family, has been utilized in Chinese medicine for centuries, and its thorns serve as a chief medicinal ingredient.
View Article and Find Full Text PDFDownregulation of the Phosphatase PHLPP1 Contributes to NNK-induced Malignant Transformation of Human Bronchial Epithelial Cells (HBECs).
J Biol Chem
January 2025
Key Laboratory of Medicine, Ministry of Education, School of Laboratory Medicine and Life Sciences, Wenzhou Medical University; Wenzhou, Zhejiang 325035, China; Oujiang Laboratory (Zhejiang Lab for Regenerative Medicine, Vision and Brain Health), Wenzhou, Zhejiang 325053, China. Electronic address:
Cigarette smoking (CS) is one of the greatest health concerns, which can cause lung cancer. 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK), a tobacco-specific nitrosamine, and has been well-documented for its carcinogenic activity in both epidemiological and laboratory studies. PH domain leucine-rich repeat protein phosphatase 1 (PHLPP1) and phosphatase and tensin homolog (PTEN) are two well-known phosphatase tumor suppressors that have been reported to be downregulated in human lung cancer tissues.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!